Articles 
0.25 CIP Points
Weight loss drugs a dilemma for insurers amid celebrity hype
While some insurers are cutting rebates for Ozempic and similar weight-loss drugs, others are waiting to see whether the long-term benefits outweigh the risks.
11 May 2026
1 min read
A
A
A
While some insurers are cutting rebates for Ozempic and similar weight-loss drugs, others are waiting to see whether the long-term benefits outweigh the risks.
Related Resources
0.25CIP Points Ask an Expert: Premium loadings in the Australian market
Q: Is it common in the Australian market to apply temporary or stepped premium loadings...
1 min read
0.25CIP Points Ask an Expert: How do fire investigations identify fraudulent claims, and what’s the impact on the policyholder?
Fire-related claims are subject to heightened scrutiny due to the potential for fraud. Fraudulent fire...
1 min read
0.25CIP Points Ask an Expert: How do insurers in the Australian market approach underwriting for CI riders when the applicant isn’t the main life insured?
Q: How do insurers in the Australian market typically approach underwriting for Critical Illness (CI)...
1 min read
0 Comments